Introduction {#section1-1178223419840694}
============

The human populace in sub-Saharan Africa is increasingly threatened by overwhelming reports of cancer incidences. In particular, recent results from population-based cancer registries have shown that cancer incidence in Nigeria is quite alarming.^[@bibr1-1178223419840694],[@bibr2-1178223419840694]^ More disturbing is the fact that over 60% of all incidences were found among women with breast cancer accounting for the highest figure.^[@bibr1-1178223419840694][@bibr2-1178223419840694]--[@bibr3-1178223419840694]^ In 2012, for instance, approximately 14 million new cancer cases were reported globally and up to 8.2 million deaths recorded from cancer in the same year, with 57% of the cases and 65% of the deaths occurring in less developed countries,^[@bibr4-1178223419840694]^ 6% of the world total of cancer cases and 7.2% of the deaths occurring in Africa which may increase by at least 70% in 2030.^[@bibr5-1178223419840694]^ In Nigeria, some 100 000 new cases of cancer occur every year, with high case fatality ratio.^[@bibr6-1178223419840694]^ With approximately 20% of the population of Africa and slightly more than half the population of West Africa, Nigeria contributed 15% to the estimated 681 000 new cases of cancer that occurred in Africa in 2008.^[@bibr7-1178223419840694]^ World Health Organization estimates that the incidence of cancer in Nigerian men and women by 2020 will be 90.7/100 000 and 100.9/100 000 and the deaths rates will be 72.7/100 000 and 76.0/100 000, respectively.^[@bibr8-1178223419840694]^

Despite its significance to public health, studies investigating chemical signatures of cancerous tissues are rare in Nigeria and perhaps in West Africa.^[@bibr1-1178223419840694],[@bibr9-1178223419840694]^ The reasons are directly linked to lack of research facilities required for such studies, inadequate and commensurate skilled manpower, and ultimately lack of research funding. Currently, Nigeria has no national policy or a comprehensive document on cancer control, neither is there any organized national programme for cancer prevention.

As a positive contribution towards the pressing need to improve the quality of services for cancer diagnosis and control in Nigeria, this study aimed at applying an advanced and highly sophisticated facility (a Tandem 1.7 MV 5SDH accelerator) hosted at the Center for Energy Research and Development (CERD), Obafemi Awolowo University to investigate the chemical compositions of cancerous and non-cancerous breast tissues as well as the whole blood of selected African women in the region. The objective is to obtain tendencies, in terms of concentration levels, for trace elements present in breast tissues as possible biomarkers for cancer occurrence and signals for early prevention therapy.

Materials and Methods {#section2-1178223419840694}
=====================

Sample collection and preparation {#section3-1178223419840694}
---------------------------------

In total, 10 specimens, each of paired cancerous and non-cancerous breast tissues, and 10 whole blood samples were obtained from mastectomy operations on patients with confirmed breast cancer diagnosis. Non-cancerous tissues were taken from regions of the breast defined by the safety margin from the same patients.^[@bibr10-1178223419840694]^ The paired-sample methodology adopted in this study was to avoid demographic uncertainty which may occur due to differences in age, diet, sexual orientation, hormonal status, medication, genetics, and other environmental factors. Deionized and double-distilled water was used to remove blood stains from the breast tissue specimen and then freeze-dried at −54°C for 32 hours. To minimize crystal formation and morphological damage, cryo-sectioned samples were quickly frozen in liquid nitrogen (--176°C) for 72 hours. Final freeze drying was carried out with a *Christ BETA1-8 LD plus* machine at 6.1 mbar for 72 hours. The specimens were then converted to a homogeneous fine powder by pulverizing in an agate mortar and subsequently pelletized into 11-mm-diameter samples required as targets in the particle-induced X-ray emission (PIXE) analytical setup.

PIXE analysis {#section4-1178223419840694}
-------------

A 1.7 MV Pelletron 5SDH tandem accelerator hosted at the CERD, Obafemi Awolowo University, Ile-Ife, Nigeria was used for PIXE analysis of the blood and breast tissues. The accelerator end station (the section where the sample was irradiated) was equipped with a multipurpose end station consisting of an aluminium chamber of about 150 cm diameter and 180 cm height. The chamber was maintained under vacuum for Rutherford backscattering (RBS), proton-induced gamma ray emission (PIGE), and PIXE analysis. For the PIXE technique employed in this study, a proton beam of energy 2.5 MeV extracted from a radiofrequency charge-exchanged ion source was focused on the samples through a 4-mm collimator and irradiation was maintained at a beam current not more than 6 nA for an average of 20 minutes. Characteristic X-ray signals emitted from the bombarded samples were collected on a highly sensitive Canberra Si-Li detector (Model ESLX 30-150, beryllium thickness of 25 µm), inclined at an angle of 135° from the incident beam. The detector has an active area of 12.5 mm^2^ and a resolution of 145 eV FWHM (full width at half maximum) at 5.9 keV. Detailed configuration parameters of the CERD accelerator have been reported elsewhere.^[@bibr11-1178223419840694],[@bibr12-1178223419840694]^ The PIXE spectrum processed by a Canberra Genie 2000 (3.1) multi-channel analyser was analysed using GUPIXWIN software. GUPIXWIN provided a non-linear least-squares fitting of the spectrum, together with subsequent conversion of the fitted X-ray peak intensities into elemental concentrations utilizing the fundamental parameter method for quantitative analysis. Sample matrix was taken into account in the GUPIXWIN analysis based on the iterative matrix element solution.

System calibration/quality assurance {#section5-1178223419840694}
------------------------------------

Two certified and appropriate reference standards: NIST 1577a (Bovine Liver) and IAEA-A-13 (Animal Blood) irradiated under the same experimental condition with the specimens and analysed with consistent fundamental parameters were used to calibrate the PIXE system for quality assurance. The efficiency of the system to replicate reference values for 10 elements (Na, Mg, P, S, K, Ca, Mn, Fe, Cu, and Zn) in the 2 standards was considered.

Results and Discussion {#section6-1178223419840694}
======================

Analytical results obtained for the 2 reference materials used for the PIXE system are presented in [Table 1](#table1-1178223419840694){ref-type="table"}, while [Table 2](#table2-1178223419840694){ref-type="table"} depicts trace element levels in breast tissues and whole blood (ppm). From [Table 1](#table1-1178223419840694){ref-type="table"}, it is clear that the experimental analyses of the bovine liver and animal blood standards adequately reproduced their certified reference values (*r* = 0.999) within and acceptable system efficiency ranging from 78.5% (Cu) to 105.1% (Mg). [Figure 1](#fig1-1178223419840694){ref-type="fig"} also shows the levels of trace element distributions in cancerous and normal tissues of clinically diagnosed patients with breast cancer.

###### 

Reference values of calibrating standards and experimental results (ppm).

![](10.1177_1178223419840694-table1)

  Elements                       Na       Mg      P        S       K       Ca      Mn      Fe      Cu
  ------------------------------ -------- ------- -------- ------- ------- ------- ------- ------- ------
  NIST 1577a (Bovine Liver)      2400     600     11 100   7800    9960    120     8.5     194     158
  Experimental values obtained   2420     602     11 300   7801    9950    120     8.6     194     124
  System efficiency (%)          100.8    100.3   101.8    100.0   100.0   100.0   100.0   101.2   78.5
  Elements                       Na       Mg      P        S       K       Ca      Fe      Zn      
  IAEA-A-13 (Animal Blood)       12 600   99      940      6500    2500    286     2400    13      
  Experimental values obtained   12 610   104     940      6480    2506    286     2402    13      
  System efficiency (%)          100.1    105.1   100      99.7    100.2   100     100.1   100     

###### 

Trace element levels in breast tissues and whole blood (ppm).

![](10.1177_1178223419840694-table2)

       Breast tissues                                            Whole blood                                                             
  ---- --------------------------------------------------------- ------------- --------------------------------------------------------- ---------------------------------------------------------
  Na   5288 ± 277                                                2320 ± 215    12 123 ± 499                                              1787 *±* 28
  Mg   428 ± 78                                                  134 ± 68      72 ± 20                                                   36 *±* 7
  Al   564 ± 41                                                  442 ± 30      275 *±* 8                                                 ^[a](#table-fn2-1178223419840694){ref-type="table-fn"}^
  Si   97 ± 25                                                   111 ± 19      30 *±* 5                                                  ^[a](#table-fn2-1178223419840694){ref-type="table-fn"}^
  P    1577 ± 20                                                 242 ± 14      1761 ± 44                                                 451 *±* 7
  S    2312 ± 21                                                 804 ± 14      6993 ± 43                                                 1221 *±* 7
  Cl   4140 ± 18                                                 2226 ± 13     17 228 ± 52                                               2475 *±* 9
  K    2863 ± 11                                                 493 ± 6       7633 ± 26                                                 1182 *±* 6
  Ca   509 ± 7                                                   348 ± 4       365 ± 20                                                  91 *±* 4
  Cr   0.9 ± 0.4                                                 4 ± 1                                                                   
  Mn   5 ± 4                                                     3 ± 1         ^[a](#table-fn2-1178223419840694){ref-type="table-fn"}^   2 *±* 1
  Fe   182 ± 3                                                   25 ± 1        2128 ± 18                                                 394 *±* 8
  Ni   ^[a](#table-fn2-1178223419840694){ref-type="table-fn"}^                 1.89 ± 1.75                                               13.00 ± 5.09
  Cu   3 ± 1                                                     2 ± 1                                                                   
  Zn   30 ± 6                                                    14 ± 4        59 ± 16                                                   31 *±* 9
  Se   5 ± 3                                                     4 ± 2         19 ± 7                                                    3 *±* 2
  Br   17 ± 10                                                   26 ± 4        63 ± 30                                                   4 *±* 3
  Rb   21 ± 9                                                    3 ± 1         0.3 ± 0.1                                                 4 *±* 4
  Sr   3 ± 1                                                     0.6 ± 0.4                                                               
  Zr   10 ± 5                                                    4 ± 1                                                                   
  Pb   17 ± 7                                                    4 ± 2                                                                   

PIXE, particle-induced X-ray emission.

Values are below the PIXE system detection limits.

![Trace element distributions in cancerous and normal tissues of clinically diagnosed patients with breast cancer.](10.1177_1178223419840694-fig1){#fig1-1178223419840694}

The levels of the observed trace elements were in the range of 0.9-5288 and 0.6-2320 ppm in breast tissues and 0.3-17 228 and 2.0-2475 ppm in the whole blood of cancerous and non-cancerous subjects, respectively. Generally, high positive correlations were obtained between the levels (mean values) of these trace elements in breast tissues of cancerous and non-cancerous patients (*r* = 0.938) as well as in the whole blood (*r* = 0.995). The elements: Na, Mg, Al, Si, P, S, Cl, K, Zn, Br, Si, Ca, Rb, and Zr were elevated in the malignant breast tissues of the cancer patients compared to the normal tissues obtained at a safety margin from the same patients as shown in [Figure 1](#fig1-1178223419840694){ref-type="fig"}. However, at the .05 level of significance, significant differences exist between the levels of Br, Mn, Se Pb, and Zn in the cancerous and non-cancerous breast tissues (*t* = 0.02-0.04).

The elevated level of electrolytes Na, Cl, K, and Ca reported by Stephen^[@bibr10-1178223419840694]^ as shown in [Figure 3](#fig3-1178223419840694){ref-type="fig"} are also in good agreement with our study. In addition, the disparity in the levels of Na detected in this study compared with the result obtained by Stephen^[@bibr10-1178223419840694]^ could be an indication of variation in dietary habit, location, or other factors. Also, the difference in concentrations of Sr and As in the subjects' malignant breast tissues compared with the 2 studies could be due to the same varying factors. However, both levels were higher than those in the normal tissues in the studies. Zirconium (Zr) detected in this study has not been reported in the literature regarding its contribution to cancer but could find its way into the tissues as a result of its use as jewelleries.

[Figure 2](#fig2-1178223419840694){ref-type="fig"} shows the PIXE spectrum of the blood, while [Figure 3](#fig3-1178223419840694){ref-type="fig"} depicts the trace element distribution in the blood of cancer and non-cancer patients.

![PIXE spectrum of blood.\
PIXE, particle-induced X-ray emission.](10.1177_1178223419840694-fig2){#fig2-1178223419840694}

![Trace element distribution in the blood of cancerous and non-cancerous patients.](10.1177_1178223419840694-fig3){#fig3-1178223419840694}

The levels of electrolytes Ca, Cl, K, and Na were higher in the blood as obtained in the malignant breast of patients with cancer ([Figure 3](#fig3-1178223419840694){ref-type="fig"}). Perhaps, this phenomenon could be used as an indicator for cancer. Virtually, all the elements found to be significantly elevated in the cancerous breast tissues were equally elevated in the blood of the subjects. The levels of Nickel were below the detection limit in the breast tissues. Also, no significant difference exits in the levels of this element in the blood of cancerous and non-cancerous patients (*t* = 0.42, at the .05 level of significance).

From [Table 1](#table1-1178223419840694){ref-type="table"}, chromium was detected in a small amount and there was no appreciable difference between its levels in malignant and normal tissues. Cr toxicity is commonly associated with exposure to hexavalent Cr compounds rather than to the low toxic trivalent Cr compounds.^[@bibr13-1178223419840694]^ Cr(VI) has a characteristic of ease of absorption by the body cells and, once in the cell, it is reduced to the trivalent state which produces genotoxic effects.

The availability or deficiency of some of these trace elements goes a long way in the formation or inhibiting cancer. Mo, Mn, and Zn have been found to prevent the formation of experimentally induced cancer, whereas the deficiency of Mo and Zn has been cited as a possible factor in the causation of oesophageal cancer.^[@bibr14-1178223419840694],[@bibr15-1178223419840694]^

According to the study conducted by Alatise and Schrauzer,^[@bibr16-1178223419840694]^ there could also exist an association of Se with its antagonistic elements. In their study, correlation calculations revealed that elements like Cr, Pb, and other oxidants interact with Se, thereby suppressing the antioxidant effects of Se. In metal-exposed subjects, a state of latent Se deficiency may exist resulting in depressed immune functions and increased cancer susceptibility. Evidence has also been shown that Pb and other metals interact with iodine, another vitally important essential trace element that is believed to protect against breast cancer development.^[@bibr16-1178223419840694]^ These observed correlations suggest that the levels of Se and other anticancer elements significantly influence the concentration of the carcinogenic or toxic elements in the affected part or the whole body.

The elevated level of Al found in this study agreed with Christopher Exley who also confirmed the presence of Al in breast tissue and its possible regional distribution within the breast.^[@bibr17-1178223419840694]^ A higher content of Al in the outer breast tissues might be due to its proximity to the underarm where the highest density of application of antiperspirant could be assumed. There is evidence that skin is permeable to Al, even when applied as an antiperspirant.^[@bibr18-1178223419840694]^

Phosphorus (P) was elevated in the malignant tissues relative to normal. The same trend was observed in the blood of cancer patients. High levels of phosphorus can affect body's ability to effectively use other minerals such as iron, calcium, magnesium, and zinc. It can combine with calcium resulting in mineral deposits in the muscles. It is rare to have too much phosphorus in the blood. Typically, only people with kidney problems or those who have problems regulating their calcium level develop this problem. A similar result was obtained by Sivakumar and Mohankumar in patients with breast cancer which was attributed to the elevation of cellular activity in malignant tissue and active enzymatic systems.^[@bibr19-1178223419840694]^,^[@bibr20-1178223419840694]^

Conclusions {#section7-1178223419840694}
===========

The study was undertaken to determine the variation in trace elemental concentrations between normal and malignant human breast tissue specimens and to understand the effects of altered homeostasis of these elements in the cause of breast cancer. Using PIXE, the observed trace elements were found within the range of 0.9-5288 and 0.6-2320 ppm in breast tissues and 0.3-17 228 and 2.0-2475 ppm in the whole blood of cancerous and non-cancerous subjects, respectively. Trace element concentrations in cancerous whole blood and malignant breast tissues were significantly or relatively higher (in most cases) than the normal (*t* = 0.008-0.041). The results established the baseline levels and indicated that PIXE is a powerful technique to investigate and evaluate trace element concentration in human blood and breast tissues, despite its advantages (being a multi-elemental technique with high levels of precision and accuracy).

Cancer disturbs the physiological functions of biological cells which are manifested in the variation of trace element concentrations in malignant and normal tissues obtained from the subjects. The difference in the concentration of some of these elements in malignant tissues in comparison with normal tissue samples indicated the possibility of using these elements as indicators or biomarkers. The elements that can be used for differentiation could be Se, Zn, and Cr which were significantly elevated in malignant tissues. Moreover, the low or high levels of some other trace elements in the observed malignant or non-malignant tissues could also be used to determine an earlier indicator of cancer and carcinogenic role, ie, the formation of free radicals or other reactive oxygen species that adversely affect DNA, thereby causing cancer-related diseases. Although some trace elements have controversial results, there is a need for more correlation investigations regarding their association with one another. For result reliability and correct assessment of the role of trace elements in initiation, promotion, progression, or inhibition of cancer in various organs, there is a need for acquisition of more data from different regions using differentials like age, gender, dietary habit, and lifestyle.

The authors are grateful to Dr (Mrs) OY Olajide, Mr and Mrs Ajala, Dr Arowolo, Dr Aladesuru, and all House Officers in the General Surgery Unit of OAUTHC for their assistance. Immense contribution made by Prof. EI Obiajunwa and other personnel in the Accelerator Laboratory during spectral acquisition and analysis of the tissue specimens is fully acknowledged.

**Funding:**The author(s) received no financial support for the research, authorship, and/or publication of this article.

**Declaration of conflicting interests:**The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: Partial fee waiver given to D.O.O. by the Management of Center for Energy Research and Development Obafemi Awolowo University, Ile-Ife, helped a great deal in concluding this work on time.

**Author Contributions:** OIA, Dr Arowolo, Dr Aledesuru liased and obtained the samples with consent of the patients. O.O.Oketayo helped in proof reading and he had acting for us as corresponding author during my rest EIO and FAB are supervisor and co supervisor of this work and AEO is in charge of the Accelerator Lab.
